
	Three Months Ended				Six Months Ended
(in thousands, except per share data)	July 27, 2025		July 28, 2024		July 27, 2025		July 28, 2024
Net loss	$	(27,064)	$	(170,295)	$	(7,719)	$	(193,454)

Weighted-average shares outstanding–basic	86,707		65,281		86,574		64,895




Weighted-average shares outstanding–diluted	86,707		65,281		86,574		64,895

Loss per share:
Basic	$	(0.31)	$	(2.61)	$	(0.09)	$	(2.98)
Diluted	$	(0.31)	$	(2.61)	$	(0.09)	$	(2.98)

Anti-dilutive shares not included in the above calculations:
Share-based compensation	1,777		911		1,667		888


Warrants	8,573		8,573		8,573		8,573
Total anti-dilutive shares	10,350		9,484		10,240		9,461

Basic earnings or loss per share is computed by dividing net income or loss available to common stockholders by the weighted-average number of shares of common stock outstanding during the reporting period. Diluted earnings or loss per share incorporates the incremental shares issuable, calculated using the treasury stock method, upon the assumed exercise of non-qualified stock options and the vesting of restricted stock units, market-condition restricted stock units and financial metric-based restricted stock units if certain conditions have been met, but excludes such incremental shares that would have an anti-dilutive effect. Due to the Company's net loss for the three and six months ended July 27, 2025 and July 28, 2024, all shares underlying stock options and restricted stock units were considered anti-dilutive.

Any dilutive effect of the 2027 Notes and 2028 Notes (as defined in Note 8, Long-Term Debt) is calculated using the if-converted method. For the three and six months ended July 27, 2025 and July 28, 2024, the 2027 Notes and 2028 Notes were excluded from diluted shares outstanding due to net loss in such reporting periods.

Any dilutive effect of the Warrants (as defined in Note 8, Long-Term Debt) is calculated using the treasury-stock method. For the three and six months ended July 27, 2025 and July 28, 2024, the Warrants were excluded from diluted shares outstanding because the exercise price exceeded the average market price of the Company's common stock for the reporting periods and due to net loss in such reporting periods.